avalglucosidase alfa Special Drug Use Investigation for patients with pompe disease
Not Applicable
Recruiting
- Conditions
- Pompe disease
- Registration Number
- JPRN-UMIN000047301
- Lead Sponsor
- Sanofi K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
-Individuals participating in or enrolling in other clinical trials involving therapeutic interventions of Nexviazyme -Those with off-label use of Nexviazyme
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method